Abstract
This chapter will describe non-dystrophic inherited myopathies and show the interest of clinical neuroradiology approaches in their diagnosis. There is a great clinical and genetic heterogeneity, and diseases are classified into different groups depending mainly on the age of onset (congenital myopathies), region of the body affected (distal myopathies), and the presence of particular structural or ultrastructural markers in the muscle biopsy (myofibrillar myopathies). Radiology, in particular muscle MRI techniques, has become a first-line complementary tool in clinical practice for this group of diseases. For diagnostic purposes, whole-body imaging techniques are preferred when involvement is axial or diffuse, as in most congenital myopathies, because of involvement of the tongue, masticator, neck, or trunk muscles. Patterns limited to lower limb muscles are better known in myofibrillar and distal myopathies. MRI protocols using T1-weighed and STIR sequences, which detect fibroadipose or inflammatory/edema changes, respectively, are widely used to identify abnormalities in muscle signal, volume, or texture. Recognizable profiles have been identified in many of these genetic myopathies. Graphical representations using heatmaps and automated algorithms allow comparing patterns and identifying key features in different myopathies, becoming an important tool to guide genetic diagnosis or to interpret next-generation sequencing results. Classic T1W and STIR protocols are progressively leaving the place to Dixon techniques, which offer not only images with similar qualitative information, useful for diagnosis (pattern recognition), but also provide quantitative data for follow-up (outcome measures). No curative treatments exist for these myopathies yet, but imaging offers a noninvasive non-radiating interesting tool expected to play an important role in future therapeutic trials.
This publication is endorsed by: European Society of Neuroradiology (www.esnr.org).
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Abbreviations
- ACTA1:
-
α (alpha)-1 actin
- AD:
-
Autosomal dominant
- AL:
-
Adductor longus muscle
- AM:
-
Adductor magnus muscle
- AR:
-
Autosomal recessive
- BAG3:
-
BCL2-associated athanogene 3 or Bag3 protein
- BF:
-
Biceps femoris short head
- BIN1:
-
Amphiphysin 2 encoding gene
- BL:
-
Biceps femoris long head
- BM:
-
Bethlem myopathy
- CACNA1S gene (protein coding):
-
Calcium voltage-gated channel subunit alpha1 S
- CCD:
-
Central core disease
- CFTD:
-
Congenital fiber-type disproportion
- CK:
-
Creatine kinase
- CM:
-
Congenital myopathy
- CMD:
-
Congenital muscular dystrophy
- CNM:
-
Centronuclear myopathy
- COL6:
-
Collagen 6
- COX:
-
Cytochrome oxidase
- CPEO:
-
Chronic progressive external ophthalmoplegia
- CRYAB:
-
αB-crystallin
- DES:
-
Desmin
- DM:
-
Dystrophic myopathies, muscular dystrophies
- DMD:
-
Duchenne muscular dystrophy
- DMRV:
-
Distal myopathy with rimmed vacuoles
- DNM2:
-
Dynamin 2
- EDMD:
-
Emery-Dreifuss muscular dystrophy
- EM:
-
Electron microscopy
- EMG:
-
Electromyography
- EPL:
-
Extensor pollicis longus muscle
- FHL1:
-
Four-and-a-half LIM domain 1 protein
- FLNC:
-
Filamin C
- FSHD:
-
Facioscapulohumeral dystrophy
- GAA:
-
Acid α (alpha)-glucosidase
- GL:
-
Gastrocnemius lateral head
- GM:
-
Gastrocnemius medial head
- GMa:
-
Gluteus maximus muscle
- GMe:
-
Gluteus medius muscle
- GMm:
-
Gluteus minimus muscle
- GNE:
-
UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine
- GR:
-
Gracilis muscle
- GSDs:
-
Glycogen storage diseases
- H&E:
-
Hematoxylin and eosin
- HIBM:
-
Hereditary inclusion body myopathy
- HMERF:
-
Hereditary myopathy with early respiratory failure
- IDEAL:
-
Iterative Decomposition of water and fat with Echo Asymmetry and Least-squares
- IL:
-
Iliacus muscle
- KSS:
-
Kearns-Sayre syndrome
- LD:
-
Latissimus dorsi muscle
- LGMD:
-
Limb girdle muscular dystrophy
- LPt:
-
Lateral pterygoid muscle
- MELAS:
-
Mitochondrial encephalomyopathy, lactic acidosis, stroke-like episodes
- MERFF:
-
Myoclonic epilepsy with ragged red fibers
- MFM:
-
Myofibrillar myopathy
- MH:
-
Malignant hyperthermia
- MmD:
-
Multi-minicore disease
- MRI:
-
Magnetic resonance imaging
- MRS:
-
Magnetic resonance spectroscopy
- MTM1:
-
Myotubularin 1 gene
- MYH7:
-
Myosin heavy chain 7, slow/β-cardiac MyHC gene
- MYOT:
-
Myotilin
- NB:
-
Nemaline bodies
- NEB:
-
Nebulin
- NM:
-
Nemaline myopathy
- PAM:
-
Protein aggregate myopathies
- RSMD1:
-
Rigid spine syndrome type 1
- RSS:
-
Rigid spine syndrome
- RYR1:
-
Ryanodine receptor type 1
- SA:
-
Sartorius muscle
- SCM:
-
Sternocleidomastoid muscle
- SEPN1:
-
Selenoprotein 1 gene
- SG:
-
Sarcoglycan
- SM:
-
Semimembranosus muscle
- SO:
-
Soleus
- ST:
-
Semitendinosus muscle
- STIR:
-
Short-tau inversion recovery
- T1W:
-
T1-weighted
- T2W:
-
T2-weighted
- TA:
-
Tibialis anterior muscle
- TFL:
-
Tensor fasciae latae muscle
- TP:
-
Tibialis posterior muscle
- TPM2:
-
Tropomyosin 2
- TPM3:
-
Tropomyosin 3
- TSE:
-
Turbo spin echo
- TTN:
-
Titin
- UCMD:
-
Ullrich type congenital muscular dystrophy
- ULN:
-
Upper limit of normal
- VI:
-
Vastus intermedius muscle
- VL:
-
Vastus lateralis muscle
- VM:
-
Vastus medialis muscle
- WBMRI:
-
Whole-body MRI
- WDM:
-
Welander distal myopathy
- XLMTM:
-
X-linked myotubular myopathy
- ZASP:
-
Z-band alternatively spliced PDZ-motif protein
- 3T:
-
3 Tesla
References
Astrea G, Schessl J, Clement E, Tosetti M, Mercuri E, Rutherford M, Cioni G, Bönnemann CG, Muntoni F, Battini R. Muscle MRI in FHL1-linked reducing body myopathy. Neuromuscul Disord. 2009;19(10):689–91.
Carlier RY, Laforet P, Wary C, Mompoint D, Laloui K, Pellegrini N, Annane D, Carlier PG, Orlikowski D. Whole-body muscle MRI in 20 patients suffering from late onset Pompe disease: involvement patterns. Neuromuscul Disord. 2011;21(11):791–9.
Carlier PG, Azzabou N, de Sousa PL, Hicks A, Boisserie JM, Amadon A, Carlier RY, Wary C, Orlikowski D, Lafôret P. Skeletal muscle quantitative nuclear magnetic resonance imaging follow-up of adult Pompe patients. J Inherit Metab Dis 2015;38(3):565–2.
Dabaj I, Carlier RY, Gómez-Andrés D, Abath Neto O, Bertini E, D’Amico A, Fattori F, Péréon Y, Castiglioni C, Rodillo E, Catteruccia M, Guimarães JB, Oliveira ASB, Reed UC, Mesrob L, Lechner D, Boland A, Deleuze JF, Malfatti E, Bonnemann C, Laporte J, Romero N, Felter A, Quijano-Roy S, Moreno CAM, Zanoteli E. Clinical and imaging hallmarks of the MYH7-related myopathy with severe axial involvement. Muscle Nerve. 2018;58:224–34. Apr 6. [Epub ahead of print]
Fischer D, Kley RA, Strach K, Meyer C, Sommer T, Eger K, Rolfs A, Meyer W, Pou A, Pradas J, Heyer CM, Grossmann A, Huebner A, Kress W, Reimann J, Schröder R, Eymard B, Fardeau M, Udd B, Goldfarb L, Vorgerd M, Olivé M. Distinct muscle imaging patterns in myofibrillar myopathies. Neurology. 2008;71(10):758–65.
Gómez-Andrés D, Dabaj I, Mompoint D, Hankiewicz K, Azzi V, Ioos C, Romero NB, Ben Yaou R, Bergounioux J, Bonne G, Richard P, Estournet B, Yves-Carlier R, Quijano-Roy S. Pediatric laminopathies: whole-body magnetic resonance imaging fingerprint and comparison with Sepn1 myopathy. Muscle Nerve. 2016;54(2):192–202.
Hankiewicz K, Carlier RY, Lazaro L, Linzoain J, Barnerias C, Gómez-Andrés D, Avila-Smirnow D, Ferreiro A, Estournet B, Guicheney P, Germain DP, Richard P, Bulacio S, Mompoint D, Quijano-Roy S. Whole-body muscle magnetic resonance imaging in SEPN1-related myopathy shows a homogeneous and recognizable pattern. Muscle Nerve. 2015;52(5):728–35.
Klein A, Jungbluth H, Clement E, Lillis S, Abbs S, Munot P, Pane M, Wraige E, Schara U, Straub V, Mercuri E, Muntoni F. Muscle magnetic resonance imaging in congenital myopathies due to ryanodine receptor type 1 gene mutations. Arch Neurol. 2011;68(9):1171–9.
Quijano-Roy S, Avila-Smirnow D, Carlier RY, WB-MRI Muscle Study Group. Whole body muscle MRI protocol: pattern recognition in early onset NM disorders. Neuromuscul Disord. 2012;22(Suppl 2):S68–84.
Romero NB, Lehtokari VL, Quijano-Roy S, Monnier N, Claeys KG, Carlier RY, Pellegrini N, Orlikowski D, Barois A, Laing NG, Lunardi J, Fardeau M, Pelin K, Wallgren-Pettersson C. Core-rod myopathy caused by mutations in the nebulin gene. Neurology. 2009;73(14):1159–61.
Susman RD, Quijano-Roy S, Yang N, Webster R, Clarke NF, Dowling J, Kennerson M, Nicholson G, Biancalana V, Ilkovski B, Flanigan KM, Arbuckle S, Malladi C, Robinson P, Vucic S, Mayer M, Romero NB, Urtizberea JA, García-Bragado F, Guicheney P, Bitoun M, Carlier RY, North KN. Expanding the clinical, pathological and MRI phenotype of DNM2-related centronuclear myopathy. Neuromuscul Disord. 2010;20(4):229–37.
Tasca G, Ricci E, Monforte M, Laschena F, Ottaviani P, Rodolico C, Barca E, Silvestri G, Iannaccone E, Mirabella M, Broccolini A. Muscle imaging findings in GNE myopathy. J Neurol. 2012;259(7):1358.
Tordjman M, et al. Muscular MRI-based algorithm to differentiate inherited myopathies presenting with spinal rigidity. Eur Radiol. 2018;28(12):5293–303. (In Press)
Further Reading
Batonnet-Pichon S, Behin A, Cabet E, Delort F, Vicart P, Lilienbaum AJ. Myofibrillar myopathies: new perspectives from animal models to potential therapeutic approaches. Neuromuscul Disord. 2017;4(1):1–15.
Carlier RY. Whole-body muscle MRI (Imagerie musculaire corps entier) (French). Cahiers de Myologie. 2014;10:22–32.
Hackman P, Udd B, Bönnemann CG, Ferreiro A, Titinopathy Database Consortium. 219th ENMC International Workshop Titinopathies International database of titin mutations and phenotypes, Heemskerk, The Netherlands, 29 April–1 May 2016. Neuromuscul Disord. 2017;27(4):396–407.
Jungbluth H, Dowling JJ, Ferreiro A, Muntoni F; RYR1 Myopathy Consortium. 217th ENMC International Workshop: RYR1-related myopathies, Naarden, The Netherlands, 29–31 January 2016. Neuromuscul Disord 2016;26(9):624–633.
Mathis S, Tazir M, Magy L, Duval F, Le Masson G, Duchesne M, Couratier P, Ghorab K, Solé G, Lacoste I, Goizet C, Vallat JM. History and current difficulties in classifying inherited myopathies and muscular dystrophies. J Neurol Sci. 2018;384:50–4.
North KN, Wang CH, Clarke N, Jungbluth H, Vainzof M, Dowling JJ, Amburgey K, Quijano-Roy S, Beggs AH, Sewry C, Laing NG, Bönnemann CG, International Standard of Care Committee for Congenital Myopathies. Approach to the diagnosis of congenital myopathies. Neuromuscul Disord. 2014;24(2):97–116.
Olivé M, Odgerel Z, Martínez A, Poza JJ, Bragado FG, Zabalza RJ, Jericó I, Gonzalez-Mera L, Shatunov A, Lee HS, Armstrong J, Maraví E, Arroyo MR, Pascual-Calvet J, Navarro C, Paradas C, Huerta M, Marquez F, Rivas EG, Pou A, Ferrer I, Goldfarb LG. Clinical and myopathological evaluation of early- and late-onset subtypes of myofibrillar myopathy. Neuromuscul Disord. 2011;21(8):533–42.
Palmio J, Udd B. Myofibrillar and distal myopathies. Rev Neurol (Paris). 2016;172(10):587–93.
Quijano-Roy S, Avila-Smirnow D, Carlier RY, Bevilacqua JA, Romero NB, Fischer D. In: Wattjes MP, Fischer D, editors. Congenital myopathies. New York: Neuromuscular Imaging (Springer); 2018.
Romero NB, Clarke NF. Congenital myopathies. Handb Clin Neurol. 2013;113:1321–36.
Tasca G, Udd B. Hereditary myopathy with early respiratory failure (HMERF): still rare, but common enough. Neuromuscul Disord. 2017;12
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Section Editor information
Rights and permissions
Copyright information
© 2019 Springer Nature Switzerland AG
About this entry
Cite this entry
Quijano-Roy, S., Carlier, R.Y. (2019). Neuroimaging in Non-dystrophic Myopathies. In: Barkhof, F., Jäger, H., Thurnher, M., Rovira, À. (eds) Clinical Neuroradiology. Springer, Cham. https://doi.org/10.1007/978-3-319-68536-6_74
Download citation
DOI: https://doi.org/10.1007/978-3-319-68536-6_74
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-68535-9
Online ISBN: 978-3-319-68536-6
eBook Packages: MedicineReference Module Medicine